Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
24%
OVERLAP
BY WEIGHT
9
# OF OVERLAPPING
HOLDINGS
HRTS
42
HOLDINGS
21%
ALSO IN OZEM
OZEM
22
HOLDINGS
43%
ALSO IN HRTS
SECTOR DRIFT (HRTS minus OZEM)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.2% | 15.5% | 10.2% |
 |
ASTRAZENECA PLC | 4.4% | 3.2% | 3.2% |
|
GILEAD SCIENCES INC | 3.8% | 2.3% | 2.3% |
|
AMGEN INC | 2.1% | 4.1% | 2.1% |
|
REGENERON PHARMACEUTICALS | 2.1% | 2.8% | 2.1% |
HRTS Overweight Relative to OZEM
 |
ROCHE HOLDINGS LTD-SPONS ADR | 5.4% |
|
JOHNSON & JOHNSON | 4.8% |
|
MERCK & CO. INC. | 4.2% |
|
THERMO FISHER SCIENTIFIC INC | 4.1% |
|
UNITEDHEALTH GROUP INC | 3.7% |
|
NOVARTIS AG | 3.3% |
|
ABBOTT LABORATORIES | 3.3% |
|
DANAHER CORP | 3.0% |
 |
MEDTRONIC PLC | 3.0% |
|
ABBVIE INC | 2.9% |
HRTS Underweight Relative to OZEM
 |
NOVO-NORDISK A/S-SPONS ADR | -18.1% |
|
ELI LILLY & CO | -5.3% |
|
ROCHE HOLDING LTD | -4.5% |
 |
ASCLETIS PHARMA, INC. | -4.4% |
|
PFIZER INC | -4.3% |
 |
HANMI PHARM CO LTD | -4.0% |
|
ZEALAND PHARMA A/S | -3.3% |
 |
SHANGHAI FOSUN PHARMACEUTI-H | -3.3% |
|
INNOVENT BIOLOGICS, INC. | -3.2% |
|
VIKING THERAPEUTICS, INC. | -2.8% |